¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 4th K-SCI(Korea-Structural Cardiovascular Intervention) Symposium : 2021-11-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 4th K-SCI(Korea-Structural Cardiovascular Intervention) Symposium : 2021-11-20
±³À°ÀÏÀÚ : 2021-11-20
±³À°Àå¼Ò : ¼­¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) ±×·£µåÄÁÆÛ·±½º·ë 401È£(4F)  
±³À°ÁÖÁ¦ : The 4th K-SCI(Korea-Structural Cardiovascular Intervention) Symposium
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ±¸Á¶½ÉÁúȯ¿¬±¸È¸  
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212  
À̸ÞÀÏ : grace@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í -Á¤È¸¿ø ¹«·á µî·Ï -Àü¹®ÀÇ/°³¿øÀÇ/ÀϹÝÀÇ: 60,000 -ÀüÀÓÀÇ/Àü°øÀÇ: 30,000 -°£È£»ç/ÀÇ·á±â»ç/ÀÇ´ë»ý/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/ÀÓ»óº´¸®»ç/Àǹ«±â·Ï»ç: 20,000 -»ê¾÷ü/±âŸ: 120,000 * ÇöÀåµî·Ï¸¸ °¡´ÉÇÕ´Ï´Ù.      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11-20 401È£ 09:10~09:20 ASD Closure in Adults with Diastolic Dysfunction and/or Pulmonary Hypertension  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 09:20~09:30 Transcatheter Closure of ASD with Complex Anatomy (Multiple Holes, Rim Deficiency)  Çϱâ¼ö(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 09:30~09:40 PFO Closure with Difficulty Anatomy; Long Tunnel, Multiple Holes  ÃÖÀ翵(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 09:40~09:50 PFO Closure in the Elderly  ÀÌÇÊÇü(¿ï»êÀÇ´ë) 
Åä·Ð 11-20 401È£ 09:50~10:10 Discussion  () 
È޽Ġ11-20  10:10~10:20 Break  () 
±³À°½Ã°£ 11-20 401È£ 10:20~10:35 TAVR in Patients with Difficult Transfemoral Access  ±èÁÖÇÑ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 10:35~10:50 TAVR in Patients with Type 0 Bicuspid AV with Heavy Calcification  ¹ÚÅñÔ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 10:50~11:05 TAVR in Patients with Low Coronary Ostium and Small SOV  À¯Ã¶¿õ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 11:05~11:20 ViV TMVR Case  Â÷Á¤ÁØ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 11:20~11:35 TAVR in Patients with Very Tortuous Aorta  ÀÌöÇö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 11:35~11:50 TAVR in Patients with Decompensated HF with Low EF  ¼­Áö¿ø(¿¬¼¼ÀÇ´ë) 
Åä·Ð 11-20 401È£ 11:50~12:00 Discussion  () 
È޽Ġ11-20  12:00~13:00 Lunch Break  () 
±³À°½Ã°£ 11-20 401È£ 13:00~13:10 Guidelines Update: How to Apply in Daily Practice?  °­¿õö(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 13:10~13:20 Update on TAVR Clinical Trials  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 13:20~13:30 Optimal Antithrombotic Therapy after TAVR  Á¶Àͼº(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 13:30~13:40 Updated Clinical Evidence on Embolic Protection Device  Àå±âÀ°(°¡Å縯ÀÇ´ë) 
Åä·Ð 11-20 401È£ 13:40~14:00 Discussion  () 
È޽Ġ11-20  14:00~14:10 Break  () 
±³À°½Ã°£ 11-20 401È£ 14:10~14:20 Secondary MR in HFrEF, How to Select the Best Candidates for Mitraclip?  ±èÁß¼±(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 14:20~14:30 Secondary MR after AMI, What Is the Optimal Timing for Mitraclip?  È«¼ºÁø(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 14:30~14:40 Mixed Primary and Secondary MR, How to Treat?  °­µµÀ±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 14:40~14:50 Mitraclip for Primary MR with Unfavorable Anatomy, How to Overcome?  È²º´Èñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 14:50~15:00 MR with Bioprosthetic Valve Failure, How to Treat?  ±¹Çüµ·(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 11-20 401È£ 15:00~15:10 Device Closure of Paravalvular Leakage after Mechanical MVR  ¾ÈÁ¤¹Î(¿ï»êÀÇ´ë) 
Åä·Ð 11-20 401È£ 15:10~15:30 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 4th K-SCI(Korea-Structural Cardiovascular Intervention) Symposium : 2021-11-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ´ç´¢º´ÇÐȸ Á¦8ȸ ´ë±¸°æºÏÁöȸ Çмú½ÉÆ÷Áö¾ö : 2021-11-20
´ÙÀ½±Û ´ëÇÑ»êºÎÀΰú·Îº¿¼ö¼úÇÐȸ Á¦ 7Â÷ ½ÉÆ÷Áö¾ö : 2021-11-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
15 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-29 0 688 2018-07-28
14 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø ¿µ»óȹµæÀÇ ±â¼úÀû Ãø¸é°ú Æó¾Ï °ËÁø : 2018-07-29 0 736 2018-07-28
13 ¼­¿ï ´ëÇѺÎÀÎÁ¾¾çÇÐȸ KGOG 2018 Summer Workshop Uterine Cancer : 2018-07-29 0 861 2018-07-28
12 ¼­¿ï ´ëÇÑ¿µ»óÀÇÇÐȸ »ó±ÙÀÇ»ç À¯¹æÃÔ¿µ¿ëÀåÄ¡ Ç°Áú°ü¸® ±³À° 3ÀÏÂ÷(7¿ù29ÀÏ) : 2018-07-29 0 796 2018-07-28
11 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-29 0 813 2018-07-28
10 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ Á¦ 18 ȸ ü°èÀû ¹®Çå °íÂû[¸ÞŸºÐ¼®]À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥ : 2018-07-28 0 1,146 2018-07-28
9 °æ±â ¸íÁöº´¿ø ¿äÃò ¹× ½½°üÀý ÅëÁõ Ä¡·áÀÇ ÃÖ½ÅÁö°ß : 2018-07-28 0 1,108 2018-07-28
8 ¼­¿ï 2018³âµµ ´ëÇÑÅëÁõÇÐȸ Á¦3Â÷ CADAVER WORKSHOP : 2018-07-28 0 1,062 2018-07-28
7 ¼­¿ï ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ 2018³â ´ëÇÑÁ¾¾ç¿Ü°úÇÐȸ ¿¬¼ö°­Á : 2018-07-28 0 985 2018-07-28
6 °æ±â ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ 2018 Pressurized Intra Peritoneal Aerosol Chemotherapy (PIPAC) Symposium : 2018-07-28 0 1,226 2018-07-28
5 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø Hyperhidrosis Symposium : 2018-07-28 0 1,514 2018-07-28
4 ¼­¿ï °¡Å縯´ëÇб³¿©Àǵµ¼º¸ðº´¿ø 2018 The 11th Catholic Neurosurgery Update Symposium : 2018-07-28 0 1,391 2018-07-28
3 °æ±â ´ëÇÑ´ç´¢º´ÇÐȸ °æÀÎÁöȸEGDM (Essential Guideline to Diabetes Management) : 2018-07-28 0 2,201 2018-07-28
2 ¼­¿ï ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¡ººÐ¼®½É¸®ÇÐ ±âÃÊ°­Á¡»: 2018-07-28 0 1,424 2018-07-28
1 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ¼ºÇü¿Ü°ú °­³² Áý´ãȸ : 2018-07-28 0 1,977 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷